Logo image
Sign in
A Phase II Evaluation of Brivanib in the Treatment of Persistent Or Recurrent Carcinoma of the Cervix: An NRG Oncology/Gynecologic Oncology Group Study
Journal article

A Phase II Evaluation of Brivanib in the Treatment of Persistent Or Recurrent Carcinoma of the Cervix: An NRG Oncology/Gynecologic Oncology Group Study

John K. Chan, Wei Deng, Robert V. Higgins, Krishnansu S. Tewari, Albert J. Bonebrake, Michael Hicks, Stephanie Gaillard, Pedro T. Ramirez, Weldon Chafe, Bradley J. Monk, …
Gynecologic Oncology, Vol.146(3), pp.554-559
09/2017

Metrics

5 Record Views

Details